KRTX insider transaction filings
Karuna Therapeutics, Inc. — 27 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-03-18. Screen KRTX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for KRTX between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Karuna Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-03-18 | 4 | Wheadon David E. — Director | Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 25,000 (derivative) @ $235.44 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · Disposition to issuer (D): 1,904 (derivative) @ $92.30 | EDGAR |
| 2024-03-18 | 4 | Torres Denice — Director | Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 25,000 (derivative) @ $225.74 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · Disposition to issuer (D): 1,904 (derivative) @ $92.30 | EDGAR |
| 2024-03-18 | 4 | Miller Andrew Craig — President of R&D | Disposition to issuer (D): 13,977 @ $330 · Disposition to issuer (D): 9,412 @ $330 · Disposition to issuer (D): 15,855 (derivative) @ $330 · Disposition to issuer (D): 47,817 (derivative) @ $327.08 · Disposition to issuer (D): 11,578 (derivative) @ $322.73 · Disposition to issuer (D): 231,992 (derivative) @ $320.80 · +4 more | EDGAR |
| 2024-03-18 | 4 | Kane William P Jr — Chief Commercial Officer | Disposition to issuer (D): 5,000 @ $330 · Disposition to issuer (D): 8,828 @ $330 · Disposition to issuer (D): 10,306 (derivative) @ $330 · Disposition to issuer (D): 29,937 (derivative) @ $137.85 | EDGAR |
| 2024-03-18 | 4 | Brown Jason Parker — Chief Financial Officer | Disposition to issuer (D): 14,009 @ $330 · Disposition to issuer (D): 7,158 @ $330 · Disposition to issuer (D): 10,306 (derivative) @ $330 · Disposition to issuer (D): 3,281 (derivative) @ $230.28 · Disposition to issuer (D): 6,562 (derivative) @ $198.36 · Disposition to issuer (D): 10,312 (derivative) @ $218.03 · +2 more | EDGAR |
| 2024-03-18 | 4 | Brannan Stephen K. — Chief Medical Officer | Disposition to issuer (D): 36,117 @ $330 · Disposition to issuer (D): 6,487 @ $330 · Disposition to issuer (D): 10,306 (derivative) @ $330 · Disposition to issuer (D): 4,677 (derivative) @ $324.55 · Disposition to issuer (D): 6,362 (derivative) @ $320.80 · Disposition to issuer (D): 50,000 (derivative) @ $230.28 · +3 more | EDGAR |
| 2024-03-18 | 4 | Pande Atul — Director | Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 12,500 (derivative) @ $232.41 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · Disposition to issuer (D): 1,904 (derivative) @ $92.30 | EDGAR |
| 2024-03-18 | 4 | OLSON LAURIE J — Director | Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 13,000 (derivative) @ $245.14 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · Disposition to issuer (D): 1,904 (derivative) @ $92.30 | EDGAR |
| 2024-03-18 | 4 | Meury William — President and CEO, Director | Disposition to issuer (D): 10,342 @ $330 · Disposition to issuer (D): 19,037 @ $330 · Disposition to issuer (D): 38,688 (derivative) @ $330 · Disposition to issuer (D): 63,065 (derivative) @ $136.81 | EDGAR |
| 2024-03-18 | 4 | HEALY JAMES — Director | Disposition to issuer (D): 32,500 @ $330 · Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 683 @ $330 · Disposition to issuer (D): 1,372,441 @ $330 · Disposition to issuer (D): 8,025 @ $330 · Disposition to issuer (D): 12,500 (derivative) @ $232.41 · +3 more | EDGAR |
| 2024-03-18 | 4 | PAUL STEVEN M — Director | Disposition to issuer (D): 2,046 @ $330 · Disposition to issuer (D): 8,550 @ $330 · Disposition to issuer (D): 30,304 @ $330 · Disposition to issuer (D): 10,000 @ $330 · Disposition to issuer (D): 33,882 @ $330 · Disposition to issuer (D): 30,304 @ $330 · +12 more | EDGAR |
| 2024-03-18 | 4 | COUGHLIN CHRISTOPHER J — Director | Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 25,000 (derivative) @ $243.35 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · Disposition to issuer (D): 976 (derivative) @ $136.81 · Disposition to issuer (D): 1,904 (derivative) @ $92.30 | EDGAR |
| 2024-03-18 | 4 | JONAS JEFFREY M — Director | Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 19,893 (derivative) @ $322.73 · Disposition to issuer (D): 16,250 (derivative) @ $314 · Disposition to issuer (D): 12,500 (derivative) @ $232.41 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · +1 more | EDGAR |
| 2024-03-11 | 4 | Brannan Stephen K. — Chief Medical Officer | Option exercise (M): 2,500 @ $5.45 · Option exercise (M): 3,209 @ $131.64 · Option exercise (M): 1,791 @ $111.97 · Sale (S): 4,900 @ $318.33 · Sale (S): 100 @ $318.96 · Option exercise (M): 2,500 (derivative) @ $0 · +2 more | EDGAR |
| 2024-03-04 | 4 | PAUL STEVEN M — Director | Other (J): 47,378 @ $315.18 · Gift (G): 30,304 @ $0 · Gift (G): 30,304 @ $0 · Gift (G): 30,304 @ $0 · Gift (G): 30,304 @ $0 · Gift (G): 30,304 @ $0 · +1 more | EDGAR |
| 2024-02-26 | 4 | PAUL STEVEN M — Director | Option exercise (M): 27,510 @ $7.27 · Option exercise (M): 4,008 @ $99.72 · Option exercise (M): 27,510 (derivative) @ $0 · Option exercise (M): 4,008 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Kane William P Jr — Chief Commercial Officer | Grant/award (A): 10,306 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Brannan Stephen K. — Chief Medical Officer | Grant/award (A): 10,306 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Brown Jason Parker — Chief Financial Officer | Tax withholding (F): 278 @ $318 · Grant/award (A): 10,306 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Miller Andrew Craig — President of R&D | Grant/award (A): 15,855 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Meury William — President and CEO, Director | Grant/award (A): 38,688 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Miller Andrew Craig — President of R&D | Tax withholding (F): 1,011 @ $317.14 | EDGAR |
| 2024-02-12 | 4 | Brannan Stephen K. — Chief Medical Officer | Option exercise (M): 2,500 @ $5.45 · Option exercise (M): 5,000 @ $111.97 · Sale (S): 4,182 @ $316.05 · Sale (S): 818 @ $316.56 · Tax withholding (F): 1,046 @ $317.14 · Option exercise (M): 2,500 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-12 | 4 | PAUL STEVEN M — Director | Tax withholding (F): 804 @ $317.14 | EDGAR |
| 2024-01-09 | 4 | Brannan Stephen K. — Chief Medical Officer | Option exercise (M): 2,500 @ $5.45 · Option exercise (M): 5,304 @ $131.64 · Option exercise (M): 9,696 @ $111.97 · Sale (S): 15,000 @ $316.81 · Option exercise (M): 2,500 (derivative) @ $0 · Option exercise (M): 5,304 (derivative) @ $0 · +1 more | EDGAR |
| 2023-12-29 | 4 | Kane William P Jr — Chief Commercial Officer | Tax withholding (F): 3,828 @ $316.30 | EDGAR |
| 2023-12-29 | 4 | Meury William — President and CEO, Director | Tax withholding (F): 8,694 @ $316.30 | EDGAR |
Recent 8-K events — Karuna Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-03-18 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-03-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-03-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-02-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2023-12-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KRTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →